A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy
Uterine leiomyosarcomas (ULMS) are a rare cause of uterine malignancy. Due to their aggressive nature, resistance to standard therapy and high rates of recurrence, they are associated with a very poor prognosis, irrespective of their stage at diagnosis. A 68-year-old female, Chinese patient was diag...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Elsevier B.V.
2024
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/44863/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|